The Andhra Pradesh MedTech Zone (AMTZ) is spearheading the new BRICS BioDesign Programme designed to advance cross-border healthcare innovation and medical technology across the member nations.The initiative was launched in New Delhi by the Principal Scientific Adviser to the Government of India, Ajay Kumar Sood, on Friday.Mr. Sood said the programme brings together global talent to solve critical healthcare challenges. He highlighted that combining scientific expertise and BioDesign accelerates the journey from ideas to implementation across the Global South.The launch featured the exchange of a Memorandum of Agreement among participating institutions and the unveiling of the official programme website.AMTZ Managing Director Jitendra Sharma said the initiative builds crucial pathways from science to patients, enabling co-development, investment, and accessible medical technologies across emerging economies.The initiative operates through a collaborative framework involving AMTZ, the Office of the Principal Scientific Adviser, the Federation of Indian Chambers of Commerce and Industry, and the Science & Technology Cluster.Industry involvement connects the BioDesign framework with commercial stakeholders and innovators to champion affordable and accessible medical technologies.The initiative unites researchers, healthcare professionals, and academic institutions across BRICS nations to accelerate the transition from concept to deployable healthcare solutions.Operating out of ‘The Atrium’ at AMTZ, the hub integrates clinical, design, engineering, prototyping, and translational capabilities to serve emerging economies across the Global South, said a release on Saturday. Published - September 12, 2026 06:49 pm IST
Vizag’s AMTZ to drive BRICS BioDesign initiative for healthcare innovation
Full Article
Original Source
Read the full article at Thehindu →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.